Discover how mindfulness practices can provide anxiety relief rivaling antidepressants, offering a natural alternative with ...

However, when feelings of intense fear and distress become overwhelming and prevent us from doing everyday activities, an anxiety disorder may be the cause. Anxiety disorders are the most common ...

In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects. Most of us have ...

Like SNRIs, tricyclic antidepressants (TCAs) increase levels of serotonin and norepinephrine. They are most helpful for people with the following conditions: Depression plus pain due to fibromyalgia, ...

Antidepressants known as selective serotonin reuptake inhibitors, or SSRIs have been the first line of treatment for mood ...

Some factors that contribute to it include: Tricyclic antidepressants (TCAs ... (clomipramine), are also used off-label for anxiety disorders like generalized anxiety disorder (GAD).

Avoid the use of activating antidepressants such as bupropion ... they account for 90% of late-life anxiety disorders. Diagnosis is difficult as comorbid psychiatric, medical, and medication ...

Antidepressants targeting the gut may treat mood disorders more safely, avoiding the side effects of traditional SSRIs, especially important during pregnancy where current SSRIs pose developmental ...

Social anxiety disorder (SAD) treatment is important for minimizing the condition's impact on your life. People with this anxiety disorder experience intense discomfort in social situations. They're ...

A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.